The Individual Investigator Research Award funds innovative research on treatments and cures for inherited retinal degenerative diseases and dry age-related macular degeneration.
Funder: Foundation Fighting Blindness
Due Dates: October 16, 2025 (LOI, FY26) | October 8, 2026 (LOI, FY27) | February 25, 2027 (Full Application, FY27)
Funding Amounts: Up to $100,000 per year for 3 years (max $300,000 total); no indirect costs allowed.
Summary: Supports research advancing treatments and cures for inherited retinal degenerative diseases and dry age-related macular degeneration.
Key Information: Open to U.S. and non-U.S. investigators; proposals must align with defined research priority areas.
The Individual Investigator Research Award (IIRA) from the Foundation Fighting Blindness is a competitive grant program supporting innovative, impactful research aimed at advancing treatments and cures for inherited retinal degenerative diseases (IRDs) and dry age-related macular degeneration (dAMD). The award targets projects that address critical gaps in the field, with an emphasis on translational, clinical, and preclinical research that can drive progress toward therapies and prevention. Research must align with one of the Foundation's six priority areas, including genetics, cell and molecular mechanisms, clinical structure and function, genetic technologies, restorative therapies, and novel medical therapies.